Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aminolevulinic acid (levulan) (1 trial)
Carcinoma, Transitional Cell (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)